Table 1 Baseline characteristics of participants by cumulative TyG index and cumulative SBP
Characteristics | Total | G1 | G2 | G3 | G4 | G5 | G6 | P value |
|---|---|---|---|---|---|---|---|---|
(N = 56,313) | (N = 18,098) | (N = 13,309) | (N = 4632) | (N = 6239) | (N = 5426) | (N = 8609) | ||
Age, years | 53.24 ± 11.92 | 49.27 ± 11.63 | 49.63 ± 10.69 | 56.86 ± 11.15 | 54.19 ± 10.55 | 62.13 ± 10.56 | 58.91 ± 10.38 | < 0.01 |
Male (%) | 43,066 (76.5) | 11,804 (65.2) | 10,565 (79.4) | 3825.0 (82.6) | 5251.0 (84.2) | 4570.0 (84.2) | 7051.0 (81.9) | < 0.01 |
CumTyG | 8.66 ± 0.55 | 8.20 ± 0.29 | 9.05 ± 0.37 | 8.26 ± 0.26 | 9.12 ± 0.40 | 8.27 ± 0.25 | 9.14 ± 0.41 | < 0.01 |
CumSBP, mmHg | 129.35 ± 16.45 | 116.08 ± 8.61 | 119.34 ± 7.30 | 134.59 ± 2.88 | 134.77 ± 2.91 | 151.76 ± 9.31 | 151.82 ± 9.20 | < 0.01 |
CumDBP, mmHg | 83.54 ± 8.93 | 77.18 ± 6.12 | 79.83 ± 5.70 | 86.18 ± 5.73 | 87.37 ± 5.62 | 91.98 ± 7.66 | 93.11 ± 7.62 | < 0.01 |
BMI, kg/m2 | 25.11 ± 3.37 | 23.63 ± 3.07 | 25.55 ± 3.09 | 24.84 ± 3.22 | 26.34 ± 3.20 | 25.21 ± 3.34 | 26.69 ± 3.38 | < 0.01 |
eGFR, mL/min/1.73 m2 | 89.85 ± 18.55 | 94.12 ± 18.11 | 93.05 ± 17.92 | 87.20 ± 17.30 | 88.44 ± 18.02 | 81.71 ± 17.44 | 83.52 ± 18.34 | < 0.01 |
Heart rate, beats/min | 73.14 ± 9.85 | 71.60 ± 9.18 | 72.90 ± 9.37 | 72.80 ± 9.70 | 74.69 ± 10.08 | 73.65 ± 10.48 | 75.49 ± 10.74 | < 0.01 |
FBG, mmol/L | 5.59 ± 1.28 | 5.13 ± 0.69 | 5.74 ± 1.38 | 5.30 ± 0.77 | 6.08 ± 1.61 | 5.41 ± 0.88 | 6.27 ± 1.70 | < 0.01 |
TC, mmol/L | 4.97 ± 0.93 | 4.72 ± 0.87 | 5.12 ± 0.93 | 4.85 ± 0.88 | 5.18 ± 0.93 | 4.89 ± 0.90 | 5.24 ± 0.97 | < 0.01 |
TG, mmol/L | 1.29 (0.91–1.90) | 0.96 (0.72–1.23) | 1.82 (1.35–2.61) | 0.99 (0.75–1.26) | 1.80 (1.33–2.64) | 0.97 (0.75–1.23) | 1.78 (1.32–2.55) | < 0.01 |
HDL-C, mmol/L | 1.55 ± 0.40 | 1.62 ± 0.41 | 1.47 ± 0.38 | 1.61 ± 0.41 | 1.47 ± 0.38 | 1.62 ± 0.41 | 1.46 ± 0.38 | < 0.01 |
LDL-C, mmol/L | 2.58 ± 0.77 | 2.43 ± 0.71 | 2.68 ± 0.74 | 2.52 ± 0.76 | 2.73 ± 0.77 | 2.50 ± 0.80 | 2.72 ± 0.83 | < 0.01 |
HsCRP, mg/L | 1.20 (0.63–2.70) | 0.97 (0.50–2.10) | 1.29 (0.70–2.67) | 1.20 (0.62–2.70) | 1.45 (0.76–3.00) | 1.40 (0.76–3.20) | 1.70 (0.81–3.40) | < 0.01 |
Physical activities (%) | 8214.0 (14.6) | 2411.0 (13.3) | 1683.0 (12.6) | 777.00 (16.8) | 929.00 (14.9) | 981.00 (18.1) | 1433.0 (16.6) | < 0.01 |
Education (%) | 15,605 (27.7) | 6308.0 (34.9) | 4632.0 (34.8) | 868.00 (18.7) | 1532.0 (24.6) | 748.00 (13.8) | 1517.0 (17.6) | < 0.01 |
Current drinker (%) | 19,937 (35.4) | 5606.0 (31.0) | 5643.0 (42.4) | 1560.0 (33.7) | 2564.0 (41.1) | 1554.0 (28.6) | 3010.0 (35.0) | < 0.01 |
Current smokers (%) | 21,641 (38.4) | 6091.0 (33.7) | 6006.0 (45.1) | 1729.0 (37.3) | 2780.0 (44.6) | 1750.0 (32.3) | 3285.0 (38.2) | < 0.01 |
Hypertension (%) | 25,949 (46.1) | 2864.0 (15.8) | 3500.0 (26.3) | 2870.0 (62.0) | 4104.0 (65.8) | 4813.0 (88.7) | 7798.0 (90.6) | < 0.01 |
Diabetes mellitus (%) | 8445.0 (15.0) | 635.00 (3.51) | 2323.0 (17.5) | 302.00 (6.52) | 1754.0 (28.1) | 485.00 (8.94) | 2946.0 (34.2) | < 0.01 |
Anti-hypertensives (%) | 7305.0 (13.0) | 333.00 (1.84) | 607.00 (4.56) | 561.00 (12.1) | 995.00 (16.0) | 1544.0 (28.5) | 3265.0 (38.0) | < 0.01 |
Antidiabetic drugs (%) | 2471.0 (4.39) | 146.00 (0.81) | 704.00 (5.29) | 79.00 (1.71) | 482.00 (7.73) | 122.00 (2.25) | 938.00 (10.9) | < 0.01 |
Lipid-lowering drugs (%) | 548.00 (0.97) | 50.00 (0.28) | 142.00 (1.07) | 19.00 (0.41) | 89.00 (1.43) | 49.00 (0.90) | 199.00 (2.32) | < 0.01 |